How much does the Pfizer version of talazoparib cost?
Talazoparib is an oral PARP inhibitor developed by Pfizer. It is mainly used to treat patients with BRCA gene mutations and HER2-negative locally advanced or metastatic breast cancer. This drug has been officially launched in China, and patients can obtain it through consultation in hospital pharmacies. However, because it is a newer targeted drug, the price is relatively high, and it is not yet fully covered by medical insurance. You need to consult local medical institutions for specific drug supply conditions.
In overseas markets, Pfizer's original drug of talazoparib has two common specifications, namely 0.25mg 30 tablets and 1mg 30 tablets. According to the latest market information, the price of 0.25mg specification is approximately between 15,000 and 20,000 yuan, while the price of 1mg specification may reach more than 50,000 yuan. Since the price is affected by exchange rates and regional differences, the actual purchase price may fluctuate. For most patients, the economic pressure of long-term use cannot be ignored.

In order to alleviate the high cost of medication, generic versions of talazoparib have been officially launched in Laos and other countries. For example, a box of 1mg*30 generic drugs produced by a Lao pharmaceutical factory sells for about 4,000 yuan, which is much lower than the original drug. This generic drug is consistent with the original drug in terms of drug composition and treatment mechanism, and is an affordable alternative for many patients.
During the period of taking talazoparib, patients should use the medication regularly under the guidance of a doctor and avoid changing the dosage or stopping the medication without authorization. At the same time, when purchasing drugs, you should obtain them through formal channels. Whether they are domestic original drugs or overseas generic drugs, you must ensure reliable sources and compliant quality to ensure therapeutic effects and drug safety.
Reference materials:https://www.talzenna.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)